awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30429169-4797755D-E7A4-488B-8271-85D988B75BEF
Q30429169-4797755D-E7A4-488B-8271-85D988B75BEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30429169-4797755D-E7A4-488B-8271-85D988B75BEF
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
P2860
Q30429169-4797755D-E7A4-488B-8271-85D988B75BEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30429169-4797755D-E7A4-488B-8271-85D988B75BEF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
13a3aaeef39a3156618460023df4e6d28506e982
P2860
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.